Ninety One (UK)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-812,021
Closed -$29.4M 325
2016
Q4
$29.4M Sell
812,021
-1,866,514
-70% -$67.7M 0.15% 137
2016
Q3
$123M Buy
2,678,535
+235,821
+10% +$10.9M 0.6% 56
2016
Q2
$123M Buy
2,442,714
+271,059
+12% +$13.6M 0.63% 56
2016
Q1
$116M Buy
2,171,655
+1,148,997
+112% +$61.5M 0.63% 59
2015
Q4
$67.1M Buy
1,022,658
+213,648
+26% +$14M 0.38% 87
2015
Q3
$45.7M Buy
809,010
+199,442
+33% +$11.3M 0.29% 96
2015
Q2
$36M Sell
609,568
-18,284
-3% -$1.08M 0.21% 117
2015
Q1
$39.1M Buy
627,852
+47,332
+8% +$2.95M 0.23% 110
2014
Q4
$33.4M Sell
580,520
-49,752
-8% -$2.86M 0.2% 115
2014
Q3
$33.9M Buy
630,272
+6,382
+1% +$343K 0.2% 121
2014
Q2
$32.7M Sell
623,890
-15,958
-2% -$837K 0.19% 130
2014
Q1
$33.8M Sell
639,848
-8,514
-1% -$450K 0.23% 115
2013
Q4
$26M Buy
648,362
+20,287
+3% +$813K 0.18% 117
2013
Q3
$23.7M Buy
628,075
+4,345
+0.7% +$164K 0.17% 120
2013
Q2
$24.5M Buy
+623,730
New +$24.5M 0.19% 123